Publications by authors named "Kimberly Jordan"

Claim this Profile
S
SM08502-Mediated β-Catenin Repression Synergizes with Olaparib to Inhibit Tumor Progression.
Bradley R Corr, Elizabeth R Woodruff, Tomomi M Yamamoto, Kimberly R Jordan, Thomas Danhorn

Cancer Res Commun· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of an immunodeficiency-associated EZH2 variant.
Francisco Perez de Los Santos, Lily Beck, Emily DeCurtis, April M Griffin, Maggie M Balas, Kimberly R Jordan

bioRxiv· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Precision Medicine in Pediatric Autoimmunity: Leniolisib Treatment of Childhood-Onset Lupus Nephritis Due to Activated Phosphoinositide 3-Kinase δ Syndrome.
Jonathan P Lim, Mansooreh Ahmadian, Hongyu Du, Christian Rickert, Tusharkanti Ghosh, Kimberly R Jordan

Arthritis Rheumatol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II Clinical Trial and Preclinical Evaluation of a Novel CD47 Blockade Combination in Refractory Microsatellite-Stable Metastatic Colorectal Cancer.
Robert W Lentz, Julie Lang, Todd M Pitts, Patrick Blatchford, Junxiao Hu, Kimberly R Jordan

Cancer Res Commun· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Platelet-Macrophage Aggregates in Remodeled Vessels of Patients With Pulmonary Arterial Hypertension.
Christine L Farrell, Mariah Jordan, Janelle N Posey, Kimberly R Jordan, Aneta Gandjeva

Pulm Circ· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Ablation of hematopoietic stem cell derived adipocytes reduces tumor burden in syngeneic mouse models of high-grade serous carcinoma.
Elizabeth R Woodruff, Courtney A Bailey, Francis To, Vyshnavi Manda, Joanne K Maltzahn, Kimberly R Jordan

bioRxiv· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of a multiplex digital PCR assay to quantify total T cells relative to chimeric antigen receptor-positive T cells.
Lindsey A Murphy, Laura Sedivy, M Eric Kohler, Kimberly R Jordan, Angela Ohm

Mol Ther Oncol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CSF1-dependent macrophage support matrisome and epithelial stress-induced keratin remodeling in Eosinophilic esophagitis.
Taylor M Benson, Gary E Markey, Juliet A Hammer, Luke Simerly, Monika Dzieciatkowska, Kimberly R Jordan

Mucosal Immunol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EHMT1/2 Inhibition Promotes Regression of Therapy-Resistant Ovarian Cancer Tumors in a CD8 T-cell-Dependent Manner.
Lily L Nguyen, Zachary L Watson, Raquel Ortega, Elizabeth R Woodruff, Kimberly R Jordan

Mol Cancer Res· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Spatial Structure of the Tumor Immune Microenvironment Can Explain and Predict Patient Response in High-Grade Serous Carcinoma.
Lucy B Van Kleunen, Mansooreh Ahmadian, Miriam D Post, Rebecca J Wolsky, Christian Rickert, Kimberly R Jordan

Cancer Immunol Res· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and immune responses to neoadjuvant fulvestrant with or without enzalutamide in ER+/Her2- breast cancer.
Anthony D Elias, Alyse W Staley, Monica Fornier, Gregory A Vidal, Vida Alami, Kimberly R Jordan

NPJ Breast Cancer· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combining EHMT and PARP Inhibition: A Strategy to Diminish Therapy-Resistant Ovarian Cancer Tumor Growth while Stimulating Immune Activation.
Lily L Nguyen, Zachary L Watson, Raquel Ortega, Elizabeth R Woodruff, Kimberly R Jordan

Mol Cancer Ther· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase II Study of Potentiation of Pembrolizumab with Binimetinib and Bevacizumab in Refractory Microsatellite-Stable Colorectal Cancer.
Robert W Lentz, Tyler J Friedrich, Patrick J Blatchford, Kimberly R Jordan, Todd M Pitts

Clin Cancer Res· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
VDX-111, a novel small molecule, induces necroptosis to inhibit ovarian cancer progression.
Christianne Persenaire, Beatrice Babbs, Tomomi M Yamamoto, Morgan Nebbia, Kimberly R Jordan

Mol Carcinog· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Microenvironment shapes small-cell lung cancer neuroendocrine states and presents therapeutic opportunities.
Parth Desai, Nobuyuki Takahashi, Rajesh Kumar, Samantha Nichols, Justin Malin, Kimberly Jordan

Cell Rep Med· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase Ib Expansion Cohort Evaluating Aurora A Kinase Inhibitor Alisertib and Dual TORC1/2 Inhibitor Sapanisertib in Patients with Advanced Solid Tumors.
S Lindsey Davis, Wells A Messersmith, W Thomas Purcell, Elaine T Lam, Bradley R Corr, Kimberly R Jordan

Cancers (Basel)· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting Tryptophan Catabolism in Ovarian Cancer to Attenuate Macrophage Infiltration and PD-L1 Expression.
Lyndsey S Crump, Jessica L Floyd, Li-Wei Kuo, Miriam D Post, Mike Bickerdike, Kimberly R Jordan

Cancer Res Commun· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SARS-CoV-2 Vaccine-Elicited Immunity after B Cell Depletion in Multiple Sclerosis.
Ryan M Baxter, Berenice Cabrera-Martinez, Tusharkanti Ghosh, Cody Rester, Miguel Guerrero Moreno, Kimberly R Jordan

Immunohorizons· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Publisher Correction: A phase I/Ib trial and biological correlate analysis of neoadjuvant SBRT with single-dose durvalumab in HPV-unrelated locally advanced HNSCC.
Laurel B Darragh, Michael M Knitz, Junxiao Hu, Eric T Clambey, Jennifer Backus, Kimberly Jordan

Nat Cancer· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The spatial structure of the tumor immune microenvironment can explain and predict patient response in high-grade serous carcinoma.
Lucy Van Kleunen, Mansooreh Ahmadian, Miriam D Post, Rebecca J Wolsky, Christian Rickert, Kimberly Jordan

bioRxiv· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A platform-independent framework for phenotyping of multiplex tissue imaging data.
Mansooreh Ahmadian, Christian Rickert, Angela Minic, Julia Wrobel, Benjamin G Bitler, Kimberly R Jordan

PLoS Comput Biol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination CDC-like kinase inhibition (CLK)/Dual-specificity tyrosine-regulated kinase (DYRK) and taxane therapy in -mutated endometrial cancer.
Bradley R Corr, Marisa R Moroney, Elizabeth Woodruff, Zachary L Watson, Kimberly R Jordan

bioRxiv· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combinatory EHMT and PARP inhibition induces an interferon response and a CD8 T cell-dependent tumor regression in PARP inhibitor-resistant models.
Lily L Nguyen, Zachary L Watson, Raquel Ortega, Elizabeth R Woodruff, Kimberly R Jordan

bioRxiv· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: A phase I/Ib trial and biological correlate analysis of neoadjuvant SBRT with single-dose durvalumab in HPV-unrelated locally advanced HNSCC.
Laurel B Darragh, Michael M Knitz, Junxiao Hu, Eric T Clambey, Jennifer Backus, Kimberly Jordan

Nat Cancer· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I/Ib trial and biological correlate analysis of neoadjuvant SBRT with single-dose durvalumab in HPV-unrelated locally advanced HNSCC.
Laurel B Darragh, Michael M Knitz, Junxiao Hu, Eric T Clambey, Jennifer Backus, Kimberly Jordan

Nat Cancer· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis